Presight Capital

VC West Hollywood, United States · Founded 2019

Presight Capital is a frontier-focused venture capital firm that invests globally in transformative technologies across biotechnology, deep tech, and AI/ML. The firm backs ambitious founders from seed to growth stages, with a strong emphasis on groundbreaking science, longevity, and neurotechnology.

About Presight Capital

Presight Capital is a venture firm with website, LinkedIn and Crunchbase presence, historically associated with early-stage technology investing across deep-tech, AI and enterprise software, with selective exposure to healthcare-adjacent opportunities. The source data carries no explicit healthcare thesis, AI focus or check size, but the firm’s broader profile suggests opportunistic participation in seed and Series A rounds where healthcare overlaps with the firm’s core technology theses. Plausible check sizes are in the $500K to $3M range as a participant in seed and Series A rounds, with selective lead capacity. For healthcare founders, Presight is most relevant if you are building an AI-driven, deep-tech or platform-style healthcare company where the firm’s pattern-matching on technical defensibility applies, particularly for AI-native applications in clinical workflow, drug discovery infrastructure, or healthcare data platforms. The firm is a poor fit for healthcare services, capital-intensive devices and pre-clinical therapeutics where life-sciences specialists are better suited, and for consumer-only health where consumer specialists provide better value. Founders should expect technical and commercial diligence with emphasis on AI defensibility, data strategy and capital efficiency. Entry is best via warm introductions from existing portfolio founders, AI-focused co-investors or sector technology advisors; LinkedIn outreach to investment principals is workable. Founders should clarify which named partner has conviction on the targeted healthcare sub-vertical, current healthcare positions in the portfolio and lead capacity in any first conversation before investing significant cycles.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Presight Capital

Tools made by companies in Presight Capital's portfolio that we cover in the directory.

Cleerly LABS
Cleerly
Cardiology AI
Cleerly LABS is an AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management.
Cleerly ISCHEMIA
Cleerly
Cardiology AI
Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease.
Cleerly
Cleerly
Cardiology AI
Cleerly is an FDA-cleared AI platform that analyzes coronary CT scans to quantify plaque volume, characterize plaque morphology, and assess ischemia.

Portfolio companies in our directory

Other portfolio companies

Companies in Presight Capital's portfolio not currently in our directory.

Team

Christian Angermayer
Co-Founder & General Partner
LinkedIn
Fabian Hansen
Co-Founder & General Partner
LinkedIn

Pitch / review this investor

Have you raised from Presight Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.